Shares of Ariad Pharmaceuticals (ARIA +9.8%) are up handsomely on the day.
Earlier, the company said it will present at the 32nd Annual JPMorgan Healthcare Conference in San Fransisco later this month.
CEO Harvey Berger will reportedly "provide an overview of the company's business." (PR)
Investors are of course focused on any commentary about Iclusig's return to market.